Try our Advanced Search for more refined results
May 08, 2012
0:12-cv-60862
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
A Florida federal judge on Monday barred Actavis from launching its generic version of Shire’s inflammatory bowel disease treatment Lialda until the patent for the drug expires in June 2020, following a second bench trial on the matter.
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login